title: Sexual differences in onset of disease and response to exercise in a transgenic model of ALS.
abstract: Transgenic mice that overexpress the mutant human SOD1 gene (hSOD1) serve as an animal model for amyotrophic lateral sclerosis (ALS). Age and sex are recognized as risk factors for ALS, but physical activity remains controversial. Therefore, we investigated the effect of exercise on the phenotype of male and female hSOD1 mice. Onset of disease, progression of disease and survival were measured in low-copy and high-copy hSOD1 mice that were randomized to an exercise or sedentary group. We found that onset of disease was different for the two sexes: significantly earlier in male than in female hSOD1 mice. Exercise delayed the onset of disease in female but not in male hSOD1 mice. Also, exercise delayed the total survival time in female high-copy hSOD1 mice. Muscle morphometry and motor neuron counts were similar in all experimental groups at the end of training. Sedentary female hSOD1 mice showed more frequently irregular estrous cycles suggesting a higher estrogen exposure in exercising female mice. These results suggest a possible neuroprotective effect of female sex hormones and support the view that ALS patients should not avoid regular exercise.
authors.affiliation: Department of Neurology, G.03.228 University Medical Center Utrecht, P.O. Box 85500, 3508 GA, Utrecht, Netherlands.
authors.forename: J H
authors.initials: JH
authors.lastname: Veldink
authors.forename: P R
authors.initials: PR
authors.lastname: Bär
authors.forename: E A J
authors.initials: EA
authors.lastname: Joosten
authors.forename: M
authors.initials: M
authors.lastname: Otten
authors.forename: J H J
authors.initials: JH
authors.lastname: Wokke
authors.forename: L H
authors.initials: LH
authors.lastname: van den Berg
mesh_terms: D000367:Age Factors; D000690:Amyotrophic Lateral Sclerosis / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology*; D000818:Animals; D002452:Cell Count; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D004195:Disease Models, Animal; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D010805:Physical Conditioning, Animal / Q000379:methods; D011897:Random Allocation; D012307:Risk Factors; D012727:Sex Characteristics; D013116:Spinal Cord / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013482:Superoxide Dismutase / Q000235:genetics / Q000378:metabolism; D013997:Time Factors
chemical_list: D004967:Estrogens; C109415:SOD1 G93A protein; D013482:Superoxide Dismutase; D002795:Choline O-Acetyltransferase